Quarterly report · Q3
4452.TEDINET S100SA96
Period2023-01-01 → 2023-09-30
Filed2023-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.13T | 2023-01-01 → 2023-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥387.4bn | 2023-07-01 → 2023-09-30d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.55T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.13T | 2022-01-01 → 2022-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥393.8bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥50.7bn | 2023-01-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥24.8bn | 2023-07-01 → 2023-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥76.9bn | 2022-01-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥23.3bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥54.6bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥25.9bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥115.8bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥85.1bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥24.6bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥32.5bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.9bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥86.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥58.3bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥19.4bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥34.5bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥16.8bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥59.5bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥19.7bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥1.75T | at 2023-09-30 | Cons. | Assets IFRS |
| Total assets | ¥1.73T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.73T | at 2022-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥727.0bn | at 2023-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥731.0bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.02T | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥995.4bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.01T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥983.9bn | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥994.4bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥972.1bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥984.5bn | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥283.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥268.2bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥240.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥336.1bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥120.3bn | 2023-01-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥130.9bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥73.2bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥50.6bn | 2023-01-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥74.9bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥58.7bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥70.9bn | 2023-01-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥139.3bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥136.8bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥70.01 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥34.24 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥183.28 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥123.82 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥41.65 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥70 | 2023-01-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥34.24 | 2023-07-01 → 2023-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥183.27 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥123.82 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥41.65 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 56.8% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.3% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.8% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-09-30 | ¥727m |
| jpcrp040300-q3r_E00883-000Chemical Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥18.5bn |
| jpcrp040300-q3r_E00883-000Consumer Products Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥31.5bn |
| jpcrp040300-q3r_E00883-000Cosmetics Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥2.8bn |
| jpcrp040300-q3r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥30.3bn |
| jpcrp040300-q3r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥5.2bn |
| jpcrp040300-q3r_E00883-000Life Care Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥1.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-09-30 | ¥50.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | ¥485m |
| jpcrp040300-q3r_E00883-000Chemical Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥26.8bn |
| jpcrp040300-q3r_E00883-000Consumer Products Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥49.6bn |
| jpcrp040300-q3r_E00883-000Cosmetics Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥3.4bn |
| jpcrp040300-q3r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥27.2bn |
| jpcrp040300-q3r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥18.9bn |
| jpcrp040300-q3r_E00883-000Life Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥24m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥76.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 834
| Item | Context | Value | Unit |
|---|---|---|---|
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | 175505000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 857251000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 270459000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 1127710000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Sales to external customers IFRS | Prior1YTDDuration | 1127710000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 33342000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 33342000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -33342000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration | - | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 370684000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 270788000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | 40274000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | 175505000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 857251000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 303801000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 1161052000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -33342000000 | JPY |
| Net sales IFRS | Prior1YTDDuration | 1127710000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 18948000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 27248000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | 24000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | 3417000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 49637000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 26795000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReportableSegmentsMember | 76432000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReconcilingItemsMember | 485000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 76917000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 8474000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 1807000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | 1511000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 85095000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 379156000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 288482000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | 40776000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | 175080000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 883494000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 242389000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_ReportableSegmentsMember | 1125883000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Sales to external customers IFRS | CurrentYTDDuration | 1125883000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |